Biotech Acquisition Company (BIOT)

NASDAQ: BIOT · IEX Real-Time Price · USD
9.90
0.00 (0.00%)
Jul 1, 2022 4:30 PM EDT - Market closed

Company Description

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses.

The company was incorporated in 2020 and is based in New York, New York.

Biotech Acquisition Company
Country United States
Founded 2020
IPO Date Jan 26, 2021
Industry Blank Check / SPAC
Employees 4

Contact Details

Address:
545 West 25th Street
New York, NY 10001
United States
Phone 212 227 1905

Stock Details

Ticker Symbol BIOT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
IPO Price $10.00
CIK Code 1825413
ISIN Number KYG1125A1085
SIC Code 2834

Key Executives

Name Position
Dr. Michael Shleifer Ph.D. Chairman and Chief Executive Officer
Thomas Fratacci Chief Financial Officer and Treasurer
Ivan Jarry Chief Operating Officer
Albert F. Hummel M.B.A. Chief Investment Officer and Director

Latest SEC Filings

Date Type Title
Jun 17, 2022 RW Registration Withdrawal Request
Jun 17, 2022 8-K Current report
Jun 13, 2022 8-K Current report
Jun 2, 2022 425 Prospectuses and communications, business combinations
Jun 2, 2022 8-K Current report
May 31, 2022 425 Prospectuses and communications, business combinations
May 31, 2022 8-K Current report
May 24, 2022 425 Prospectuses and communications, business combinations
May 23, 2022 424B3 Prospectus [Rule 424(b)(3)]
May 23, 2022 425 Prospectuses and communications, business combinations